BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21558416)

  • 1. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
    Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
    J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.
    Cohen E; Taraboulos A
    EMBO J; 2003 Feb; 22(3):404-17. PubMed ID: 12554642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicle-mediated secretion of misfolded prion protein molecules from cyclosporin A-treated cells.
    Pan I; Roitenberg N; Cohen E
    FASEB J; 2018 Mar; 32(3):1479-1492. PubMed ID: 29127190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?
    Fornai F; Ferrucci M; Gesi M; Bandettini di Poggio A; Giorgi FS; Biagioni F; Paparelli A
    Brain Res Bull; 2006 Mar; 69(2):95-100. PubMed ID: 16533656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP-containing aggresomes are cytosolic components of an ER quality control mechanism.
    Dubnikov T; Ben-Gedalya T; Reiner R; Hoepfner D; Cabral WA; Marini JC; Cohen E
    J Cell Sci; 2016 Oct; 129(19):3635-3647. PubMed ID: 27550517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggresomes do not represent a general cellular response to protein misfolding in mammalian cells.
    Beaudoin S; Goggin K; Bissonnette C; Grenier C; Roucou X
    BMC Cell Biol; 2008 Oct; 9():59. PubMed ID: 18937858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
    Apodaca J; Kim I; Rao H
    Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
    Lin Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggresome formation.
    Corboy MJ; Thomas PJ; Wigley WC
    Methods Mol Biol; 2005; 301():305-27. PubMed ID: 15917642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggresomes: a cellular response to misfolded proteins.
    Johnston JA; Ward CL; Kopito RR
    J Cell Biol; 1998 Dec; 143(7):1883-98. PubMed ID: 9864362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of lumenal prion protein aggregates by post-ER quality control mechanisms is mediated by the preoctarepeat region of PrP.
    Gilch S; Nunziante M; Ertmer A; Wopfner F; Laszlo L; Schätzl HM
    Traffic; 2004 Apr; 5(4):300-13. PubMed ID: 15030571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis.
    Bragason BT; Palsdottir A
    Mol Cell Neurosci; 2005 Jun; 29(2):232-44. PubMed ID: 15911347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Proteasome inhibitors induce nuclear ribonucleoprotein inclusions that accumulate several key factors of neurodegenerative diseases and cancer.
    Latonen L
    Bioessays; 2011 May; 33(5):386-95. PubMed ID: 21425306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
    Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
    J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.
    Rodriguez-Gonzalez A; Lin T; Ikeda AK; Simms-Waldrip T; Fu C; Sakamoto KM
    Cancer Res; 2008 Apr; 68(8):2557-60. PubMed ID: 18413721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition.
    Moll L; Ben-Gedalya T; Reuveni H; Cohen E
    FASEB J; 2016 Apr; 30(4):1656-69. PubMed ID: 26722006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.